header-logo header-logo

Home Login E-newsletter About us
15 May 2015
Issue: 7652 / Categories: Case law , Law digest , In Court
printer mail-detail

Patent

© Copyright LexisNexis 2026. All Rights Reserved.

Novartis AG and others v Focus pharmaceuticals Ltd and others; Novartis AG and others v Teva UK Ltd [2015] EWHC 1068 (Pat), [2015] All ER (D) 233 (Apr)

The Patents Court considered a claim for infringement of European Patent (UK) No 2 292 219 directed to the use of rivastigmine for use in the treatment of Alzheimer’s disease wherein the rivastigmine was administered by a transdermal therapeutic system. The court held that the patent was invalid on the ground of added matter and since the claimed invention lacked an inventive step over a previous patent.

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Read All
Sponsored by
EIP—Stuart Malcolm

EIP—Stuart Malcolm

EIP strengthens Commercial practice with a new partner

Ellisons—Francesca Brown

Ellisons—Francesca Brown

Ellisons welcomes Francesca Brown to Family team

Shakespeare Martineau—Marie Bourke

Shakespeare Martineau—Marie Bourke

Shakespeare Martineau strengthens Sheffield regulatory practice with new hires

NEWS
Read All
NLJ this week: A cautionary tale of bankruptcy and digital promises
A wide-ranging Civil Way column highlights developments from insolvency procedure to employment law, but one case stands out for its lessons on bankruptcy, family homes and digital communications
NLJ this week: Trade mark reality check for expanding brands
A sprawling Intellectual Property Office battle between House of Fraser and Frasers Property has delivered a masterclass in modern trade mark law
NLJ this week: Relocation battles demand more than good intentions
Courts in England and Wales and Singapore are increasingly confronting complex disputes over international child relocation as families become more globally mobile
NLJ this week: Domestic abuse reform faces its hardest test
The government’s long-awaited family law reform consultation could mark a turning point for domestic abuse victims navigating financial remedy proceedings, but significant challenges remain
NLJ this week: Open justice push brings experts into the spotlight
A new commercial court pilot giving the public access to documents used in hearings, including expert reports, is raising difficult questions about transparency and privacy
Copyright © 2026 LexisNexis
back-to-top-scroll